Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
LEP has formulated a line of products including CANNAVERA™, a family of topical pain relief products currently pending for over-the-counter (OTC) registration with the FDA.
Lead Product(s): Cannabis Sativa,Eugenia Caryophyllus Flower Oil,Rosmarinus Officinalis Leaf Extract
Therapeutic Area: Neurology Product Name: Cannavera
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Edge Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 12, 2021